Mitigating risks of the Opioid Therapy Program

PDL has some advice on common incidents involving the Opioid Therapy Program, following last year’s changes Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program (OTP) in 2023, overcoming numerous challenges whilst maintaining uninterrupted service to their patients. With pharmacists now becoming accustomed to these changes, the PDL Professional Officers